قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Teva gets FDA approval for 1st generic nasal spray of overdose

Teva gets FDA approval for 1st generic nasal spray of overdose



AP – USA regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses.

The Food and Drug Administration on Friday delivered advances to the naloxone spray from Israel's Teva Pharmaceuticals.

Naloxon has been sold as a nasal spray in the United States since 2016 under the Narcan brand. Pharmacists can dispense it without a prescription. It is also sold as a generic or brand name substance in automatic injectors, pre-filled syringes and vials.

A package of two Narcan nasal sprays costs about $ 1

30 to $ 150 without insurance. Teva did not immediately award the product, or when it was available its offices were closed on Friday.

More than 47,600 Americans died of opioid overdoses in 2017, a toll that has risen for two decades.


Source link